Cargando…

Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta‐analysis of three large randomized trials

BACKGROUND: Aspirin is of moderate overall benefit for patients with acute disabling ischemic stroke. It is unclear whether functional outcome could be improved after stroke by targeting aspirin to patients with a high risk of recurrent thrombosis or a low risk of haemorrhage. AIMS: We aimed to dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, Douglas D., Murray, Gordon D., Candelise, Livia, Chen, Zhengming, Sandercock, Peter A. G., Whiteley, William N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973666/ https://www.ncbi.nlm.nih.gov/pubmed/25864571 http://dx.doi.org/10.1111/ijs.12487

Ejemplares similares

Predicting risks and benefits of treatment with aspirin in the acute stage of ischaemic stroke: an analysis of 3 large randomised controlled trials
por: Thompson, Douglas, et al.
Publicado: (2013)

Comparison of Statistical and Clinical Predictions of Functional Outcome after Ischemic Stroke
por: Thompson, Douglas D., et al.
Publicado: (2014)

The risks and benefits of RTPA in acute ischemic stroke for patients at high risk of intracranial haemorrhage and poor functional outcome: a secondary analysis of the IST-3 trial and systematic review of prediction models
por: Thompson, Douglas, et al.
Publicado: (2013)

Prediction of recurrent stroke and myocardial infarction after stroke: a systematic review of clinical prediction models
por: Thompson, Douglas, et al.
Publicado: (2013)

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial
por: Amarenco, Pierre, et al.
Publicado: (2020)

Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?
por: Schmaier, Alec A., et al.
Publicado: (2018)

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
por: Johnston, S. Claiborne, et al.
Publicado: (2021)

A novel measure of treatment benefit for an ordinal scale: a case study of the IST-1 and the IST-3 stroke trials
por: Thompson, Douglas, et al.
Publicado: (2013)

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
por: Chen, Jigang, et al.
Publicado: (2022)

Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials
por: Whiteley, William N, et al.
Publicado: (2013)

Formal and informal prediction of recurrent stroke and myocardial infarction after stroke: a systematic review and evaluation of clinical prediction models in a new cohort
por: Thompson, Douglas D, et al.
Publicado: (2014)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial
por: Price, Jackie F, et al.
Publicado: (2008)

Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis
por: Yang, Youwen, et al.
Publicado: (2021)

Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis
por: Li, Mingxia, et al.
Publicado: (2023)

Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia
por: Roman-Gonzalez, Alejandro, et al.
Publicado: (2021)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
por: Khazaei, Mojtaba, et al.
Publicado: (2019)

Practical methods for ordinal data meta-analysis in stroke
por: Krishan, Ashma, et al.
Publicado: (2013)

Aspirin Resistance in the Acute Stages of Acute Ischemic Stroke Is Associated with the Development of New Ischemic Lesions
por: Kim, Joon-Tae, et al.
Publicado: (2015)

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
por: Amarenco, Pierre, et al.
Publicado: (2020)

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack
por: Wang, Yongjun, et al.
Publicado: (2022)

The Benefit and Safety of Aspirin for Primary Prevention of Ischemic Stroke: A Meta-Analysis of Randomized Trials
por: Lei, Hong, et al.
Publicado: (2016)

Biochemical aspirin resistance is associated with increased stroke severity and infarct volumes in ischemic stroke patients
por: Cheng, Xuan, et al.
Publicado: (2017)

Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke
por: Chen, Siqia, et al.
Publicado: (2017)

Aspirin resistance and blood biomarkers in predicting ischemic stroke recurrence: An exploratory study
por: Dash, Prerana, et al.
Publicado: (2022)

Aspirin for primary prevention of stroke in individuals without cardiovascular disease—A meta-analysis
por: Judge, Conor, et al.
Publicado: (2019)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis
por: Tan, Shuai, et al.
Publicado: (2015)

An investigation into the impact of enteric coated of aspirin in patients with newly diagnosed ischemic stroke (ECASIS)
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020)

Cerebral Microbleed Burden in Ischemic Stroke Patients on Aspirin: Prospective Cohort of Intracranial Hemorrhage
por: Xu, Chong-xi, et al.
Publicado: (2021)

Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack—Protocol for a systematic review and network meta-analysis
por: Zitikyte, Gabriele, et al.
Publicado: (2021)

Do patients with large vessel occlusion ischemic stroke harboring prestroke disability benefit from thrombectomy?
por: Larsson, Alice, et al.
Publicado: (2020)

Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6
por: Whiteley, William, et al.
Publicado: (2009)

Does intermittent pneumatic compression reduce the risk of post stroke deep vein thrombosis? The CLOTS 3 trial: statistical analysis plan
por: Dennis, Martin, et al.
Publicado: (2013)

Study of Pharmacodynamic and Pharmacokinetic Interaction of Bojungikki-Tang with Aspirin in Healthy Subjects and Ischemic Stroke Patients
por: Yoo, Jung-Hwa, et al.
Publicado: (2018)

Prestroke Aspirin Use is Associated with Clinical Outcomes in Ischemic Stroke Patients with Atherothrombosis, Small Artery Disease, and Cardioembolic Stroke
por: Lin, Jing, et al.
Publicado: (2019)

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design
por: Johnston, S Claiborne, et al.
Publicado: (2019)

Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Paciaroni, Maurizio, et al.
Publicado: (2019)

Large animal ischemic stroke models: replicating human stroke pathophysiology
por: Kaiser, Erin E., et al.
Publicado: (2020)

Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial
por: Chen, Ying, et al.
Publicado: (2022)

The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bisugm2o7eodhdktv2s9dgfal9